● Latest
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA) Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment RIG 101 Trial in Healthy Adults and Adults With Asthma
Sign In Register Free
All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Infectious Disease Men's Health Mental Health / Psychiatry Neurology Oncology Rare Diseases Respiratory / COPD / Asthma Rheumatology
NICE MHRA NHS England SIGN

Clinical Guidelines

Latest NICE, MHRA, NHS England and SIGN guidelines — updated automatically.

Filter: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Infectious Disease Mental Health / Psychiatry Neurology Oncology Rare Diseases Respiratory / COPD / Asthma
NICE Oncology 19 Mar 2026

Kidney cancer

Source: NICE View full guideline on NICE See full guideline on NICE website. ClinicalIQ Editorial Note: Sourced from NICE. Always refer to the original for clinical decisions. Verified: 25 Mar…

Join 10,000+ UK Clinicians

Get weekly clinical updates — guidelines, trials, MHRA alerts — delivered to your inbox. Free for verified HCPs.

By registering you confirm you are a healthcare professional. No spam. Unsubscribe anytime.